Zylo Therapeutics Inc. — Form D
Zylo Therapeutics Inc. of GREENVILLE, SC, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-13. The offering totals $4.0M, of which $3.4M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-06-13
- Form: D
- Accession: 0001721431-19-000006
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.4M
- Remaining: $592K
- Investors: 32
- Date of first sale: 2019-05-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-341828
Issuer
- Name: Zylo Therapeutics Inc.
- CIK: 0001721431
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 105A BEN HAMBY DRIVE, GREENVILLE, SC, 29615
- Phone: 858-775-6710
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| MICHAEL ZVI RABIN | Executive Officer | GREENVILLE, SC |
| LANCE MICHAEL WHITE | Director | GREENVILLE, SC |
| James MICHAEL Cordes | Director | Greenville, SC |
| SCOTT RUTLEDGE PANCOAST | Director | GREENVILLE, SC |
| SCOTT RUTLEDGE PANCOAST | Executive Officer | GREENVILLE, SC |
| SCOTT RUTLEDGE PANCOAST | Promoter | GREENVILLE, SC |
| Matt MICHAEL Dunbar | Director | GREENVILLE, SC |
| Charles E Hinkle | Executive Officer | Greenville, SC |
| Thomas Patrick Murray | Executive Officer | Kings Mill, OH |
| Gary J Atkinson | Director | Encinitas, CA |
Other filings by this issuer (2)
More